7 August 2020
Remdesivir is not in the Malaysian treatment protocol for Covid-19, says Dr Adham Baba.
Tag: compulsory licence
29 July 2020
Charles Santiago says Malaysians can’t afford the total remdesivir price of RM10,000 per patient.
4 December 2019
Gilead announced in August 2017 the expansion of its sofosbuvir voluntary licensing programme to Malaysia.
13 November 2019
Only over 50,000 high-risk people were screened this year, out of an estimated 500,000 Malaysians living with Hepatitis C.